Matthew E. Burow
- Cancer Research top 0.5%
- MicroRNA in disease regulation 16
- Cancer-related molecular mechanisms research 12
- Oncology top 1%
- Cancer Cells and Metastasis 41
- Cytokine Signaling Pathways and Interactions 13
- Molecular Biology top 1%
- Melanoma and MAPK Pathways 17
- Histone Deacetylase Inhibitors Research 12
- Biochemistry top 1%
-
- Phytoestrogen effects and research 24
-
- Estrogen and related hormone effects 36
- Co-authors
- John A. McLachlanBarbara S. BeckmanBridgette M. Collins‐BurowSteven ElliottLyndsay V. RhodesChristopher B. WeldonBruce A. BunnellAmy L. Strong
- Journals
- Breast Cancer Research (7 papers)Cancer Research (6 papers)Journal of Agricultural and Food Chemistry (6 papers)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
Matthew E. Burow
191 papers receiving 8.7k citations
Peers
Comparison fields: 5 of 153
- Cancer Research 1.8k
- Oncology 2.1k
- Molecular Biology 4.7k
- Biochemistry 365
- Pathology and Forensic Medicine 891
Countries citing papers authored by Matthew E. Burow
This map shows the geographic impact of Matthew E. Burow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew E. Burow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew E. Burow more than expected).
Fields of papers citing papers by Matthew E. Burow
This network shows the impact of papers produced by Matthew E. Burow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew E. Burow. The network helps show where Matthew E. Burow may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Matthew E. Burow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 14 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 7 | |
| 6 | 2022 | 13 | |
| 7 | 2021 | 20 | |
| 8 | 2020 | 12 | |
| 9 | 2017 | 13 | |
| 10 | 2017 | 40 | |
| 11 | Dual regulation by microRNA-200b-3p and microRNA-200b-5p in the inhibition of epithelial-to-mesenchymal transition in triple-negative breast cancer | 2015 | 1 |
| 12 | 2014 | 33 | |
| 13 | 2013 | 95 | |
| 14 | 2012 | 96 | |
| 15 | 2011 | 97 | |
| 16 | Glyceollins, a Novel Class of Antiestrogenic Phytoalexins | 2010 | 11 |
| 17 | 2010 | 120 | |
| 18 | 2008 | 21 | |
| 19 | 2003 | 251 | |
| 20 | 2003 | 19 |
About Matthew E. Burow
Matthew E. Burow is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 200 papers that have together received 9.0k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (41 papers), Estrogen and related hormone effects (36 papers), Phytoestrogen effects and research (24 papers), Melanoma and MAPK Pathways (17 papers), MicroRNA in disease regulation (16 papers), Cytokine Signaling Pathways and Interactions (13 papers), Histone Deacetylase Inhibitors Research (12 papers) and Cancer-related molecular mechanisms research (12 papers). The work is most often cited by research in Cancer Research (1.8k citations), Oncology (2.1k citations) and Molecular Biology (4.7k citations). Matthew E. Burow has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include John A. McLachlan, Barbara S. Beckman, Bridgette M. Collins‐Burow, Steven Elliott, Lyndsay V. Rhodes, Christopher B. Weldon, Bruce A. Bunnell, Amy L. Strong, Stephen M. Boué and Kenneth P. Nephew. Their work appears in journals such as Breast Cancer Research, Cancer Research, Journal of Agricultural and Food Chemistry, PLoS ONE and Molecular Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.